The South America Hydrogel Market is anticipated to add to more than USD 360 Million by 2026-31.
The South America hydrogel market is developing through increasing demand for advanced wound-care products, expanding pharmaceutical and healthcare industries, growing agricultural water management requirements, and rising research activity in biomaterials. Brazil represents a major regional opportunity because of its large healthcare system, domestic chemical manufacturing capabilities, agricultural sector, and expanding medical technology industry. Argentina, Chile, Colombia, and other South American countries offer additional opportunities through hospital modernisation, pharmaceutical distribution, agricultural productivity initiatives, and increasing access to specialised wound care treatments. Hydrogels are used in wound dressings, drug-delivery systems, contact lenses, personal care products, laboratory research, and agricultural soil conditioners, with demand varying considerably according to local industrial capabilities and purchasing power. Regulatory oversight is particularly important for medical grade hydrogels because product classification depends on intended use, composition, biological interaction, and therapeutic claims. In Brazil, the National Health Surveillance Agency (ANVISA) regulates medical devices under applicable requirements, including Resolution RDC 751/2022 on classification, notification, and registration and RDC 848/2024 on essential safety and performance requirements. Lower risk devices may follow notification procedures, while higher-risk devices generally require a more comprehensive registration process and supporting evidence. Applicable manufacturing, labelling, biocompatibility, quality management, and post market obligations must also be considered. According to the research report, "South America Hydrogel Market Outlook, 2031," published by Bonafide Research, the South America Hydrogel Market is anticipated to add to more than USD 360 Million by 2026-31.Argentina regulates medical products through the National Administration of Drugs, Foods and Medical Devices (ANMAT), while Colombia's National Institute for Food and Drug Surveillance (INVIMA) oversees relevant medical device registration and market surveillance. Chile's Institute of Public Health (ISP) administers applicable medical device controls, with requirements depending on the product category and current regulatory provisions. Manufacturers should verify country-specific rules before importing or commercialising a hydrogel product because approval in one South American country does not automatically authorise sale throughout the region. Government policies supporting domestic pharmaceutical and medical device production, scientific research, agricultural productivity, and public healthcare can indirectly support hydrogel adoption. Brazil's healthcare innovation ecosystem and university research networks provide opportunities for developing locally manufactured biomaterials, while agricultural sustainability programmes and demand for more efficient irrigation create potential applications for water-retaining hydrogels. Further opportunities include antimicrobial wound dressings, hydrogel-based drug delivery, biodegradable agricultural formulations, tissue engineering, and affordable products designed for public hospitals and community healthcare settings. Brazil is an important regional manufacturing and consumption centre, while other countries rely more heavily on imports and international distribution networks for specialised medical materials. Key raw materials include acrylic acid, sodium acrylate, polyacrylamide, polyethylene glycol, polyvinyl alcohol, sodium alginate, gelatin, hyaluronic acid, cellulose derivatives, and other natural and synthetic polymers.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Product Type | Synthetic Hydrogel | |
| Natural Hydrogel | ||
| Hybrid Hydrogel | ||
| By Application | Personal Care & Hygiene | |
| Wound Care | ||
| Contact Lenses | ||
| Agriculture | ||
| Drug Delivery | ||
| Others | ||
| By Composition | Polyacrylate | |
| Polyacrylamide | ||
| Silicone-modified Hydrogels | ||
| Others (Agar-based, alginate-based, gelatin-based, cellulose-based and other formulations) | ||
| By Form | Amorphous | |
| Semi-Crystalline | ||
| Crystalline | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
Synthetic hydrogel leads and is positioned for the fastest growth in the South America Hydrogel Market because its adjustable absorption and formulation consistency make it suitable for expanding wound care applications, pharmaceutical research and agricultural water management solutions. Synthetic hydrogels have an important advantage in South America because manufacturers can engineer their properties to meet specific application requirements rather than relying on the variable characteristics of naturally occurring materials. Polymers such as polyvinyl alcohol (PVA), polyacrylic acid derivatives, and polyethylene glycol can be formulated into networks with different levels of water absorption, elasticity, porosity, and mechanical strength. These characteristics are particularly relevant to healthcare, where a hydrogel dressing may need to absorb wound fluid while maintaining a moist environment and remaining sufficiently stable during use. Brazil provides a concrete example of regional research activity: scientists associated with São Paulo research institutions developed an experimental hydrogel containing an anti-inflammatory peptide for investigating diabetic wound healing, demonstrating how hydrogel formulations can be adapted to address specific clinical needs. The work was reported by the São Paulo Research Foundation and published in Biomedicine & Pharmacotherapy, although the formulation should not be interpreted as proof of widespread commercial adoption. Synthetic polymers also offer researchers opportunities to control how a hydrogel releases an incorporated substance, which is relevant to pharmaceutical delivery systems and the development of advanced wound care materials. PVA-based hydrogels, for example, have been investigated for wound dressings, tissue engineering, drug delivery, and ophthalmic applications because their mechanical behaviour and water content can be modified through processing and crosslinking methods. Drug delivery is the fastest-growing application of hydrogels in South America because research into controlled release polymer systems is creating opportunities to improve drug stability and develop more targeted delivery approaches for complex treatments. Hydrogels are gaining research attention in drug delivery because their water rich, three dimensional polymer networks can hold therapeutic compounds and release them as the material swells, degrades, or responds to changes in its surrounding environment. This function is relevant to South America, particularly Brazil, where university laboratories have investigated hydrogel formulations for different pharmaceutical purposes. The research, supported by the São Paulo Research Foundation, demonstrated how a specially designed polymer network could accommodate compounds with different affinities for water, illustrating the potential of hydrogels to support combination delivery strategies. Another example comes from research published in the Brazilian Journal of Pharmaceutical Sciences, in which scientists at São Paulo State University prepared a dextran based hydrogel containing praziquantel and observed gradual, sustained drug release during laboratory dissolution testing. This finding demonstrated the potential of the polymer as a carrier, although it did not establish that the formulation had become a commercially approved medicine. Such investigations matter because conventional dosage forms may not always provide the desired release profile, particularly when a treatment requires prolonged exposure, improved delivery of poorly water soluble compounds, or release under specific physiological conditions. South America's pharmaceutical research institutions can use these approaches to explore applications in wound treatment, local drug administration, cancer-related research, and other therapeutic areas. Polyacrylate leads and demonstrates strong growth potential in the South America Hydrogel Market because its high water absorption capacity and established use in agricultural water management and advanced wound care products make it suitable for the region's practical industrial and environmental needs. Polyacrylate based hydrogels stand out in South America because they can be engineered to manage water efficiently in settings where moisture retention, liquid absorption, and dependable material performance are important. These hydrogels are generally produced by crosslinking acrylic acid or its salts, creating a three-dimensional polymer network that swells when exposed to water but does not simply dissolve. The network's structure allows it to retain liquid and release some of that moisture as surrounding conditions change, making polyacrylate useful in selected agricultural, medical, and personal-care applications. The study found that adding the polymer increased water retention in sandy soil under the tested conditions, while also showing that irrigation water salinity could reduce absorption and that the benefits were affected by application conditions. These findings demonstrate both the practical potential and the limitations of agricultural hydrogels. Agricultural applications are particularly relevant because polymeric hydrogels can act as small water reservoirs in soil, helping retain moisture near plant roots and potentially reducing water losses through drainage. A review by researchers affiliated with Brazilian agricultural and university institutions identifies soil water retention, controlled nutrient delivery, and improved water use efficiency as important areas of hydrogel research. Polyacrylate based materials also have uses in wound care products, where superabsorbent components can collect and retain wound exudate and help maintain an appropriate environment around the wound. Amorphous hydrogel is the fastest growing form in the South America Hydrogel Market because its spreadable, shape adapting consistency makes it particularly useful for treating irregular or slough covered wounds, where direct moisture delivery and easier application can support practical wound management needs. Unlike preformed hydrogel sheets, amorphous hydrogels are supplied as soft gels that can be dispensed from tubes or containers and applied directly to a wound surface or cavity. This format provides flexibility for healthcare professionals managing wounds with uneven contours, narrow spaces, or areas where a flat dressing may not maintain adequate contact. Amorphous formulations commonly contain water combined with hydrophilic polymers or thickening agents, such as modified starch or cellulose-based materials, which help the gel retain its consistency during application. By donating moisture to dry or slough covered tissue, these products can soften devitalised material and support autolytic debridement, the natural process through which the body's enzymes help separate damaged tissue from the wound bed. Clinical guidance identifies amorphous hydrogels as a suitable option for selected pressure ulcers with depth or irregular contours, particularly when a dressing could otherwise shift during movement. These characteristics are relevant to South America's healthcare sector, where wound management may involve chronic ulcers, diabetic foot wounds, pressure injuries, burns, and postoperative wounds. Brazil's large healthcare system and established medical product distribution networks provide a potential setting for broader access to advanced wound care materials, while clinical education and improved access to specialised dressings can influence adoption.
to Download this information in a PDF
Colombia is the fastest-growing market for hydrogels in South America because its established healthcare system, expanding pharmaceutical and strategic role in regional healthcare distribution create favourable conditions for wider adoption of hydrogel based products. Colombia's growth potential in the hydrogel market is closely linked to the development of its healthcare infrastructure and its role as a pharmaceutical and medical-product distribution centre for neighbouring Latin American countries. The country's healthcare system provides broad population coverage, creating an established setting for the use of wound dressings, medical materials, pharmaceutical formulations, and other products that may incorporate hydrogel technology. According to Invest in Colombia, approximately 98% of the population was covered by the healthcare system in 2024, while the country's pharmaceutical industry benefits from domestic manufacturing capabilities, multinational company participation, and established export channels. These factors provide a commercial foundation for introducing specialised medical products, although healthcare coverage alone does not establish the extent of hydrogel use. One relevant application is advanced wound care. Hydrogels can absorb or donate moisture depending on their formulation, helping maintain a suitable wound environment and supporting the management of selected burns, ulcers, and other injuries. Their soft, water-rich structure also makes them useful in research involving controlled drug delivery, tissue engineering, and biomaterials. Colombia's medical-device regulatory framework is another important consideration. Decree 4725 of 2005 establishes requirements for the registration, marketing authorisation, and surveillance of medical devices, while Resolution 184 of 2024 adopted a national medical-device policy intended to strengthen access, safety, availability, and appropriate use.
to Download this information in a PDF

We are friendly and approachable, give us a call.